The number of people with diabetes is growing to epidemic proportions in the United States. There is a great deal of research on the evolving understanding of the pathogenesis of diabetes as compared to normoglycemia. The diagnostic criteria for diabetes have become streamlined to more appropriately and accurately diagnose the disease. There are millions of people who have diabetes, but do not know it. It is essential that appropriate screening be performed to make a diagnosis in order to delay or prevent the complications from occurring. The complications of diabetes have implications for the increasing number of people with the diagnosis who are hospitalized and how they are treated. There are specific methods for recognition and treatment of both acute and chronic complications in the hospitalized patent with diabetes. Managing blood glucose control is essential for favorable outcomes.
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THE BURDEN OF DIABETES
Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both. The chronic hyperglycemia of diabetes is associated with longterm damage, dysfunction, and failure of various organs, especially the eyes, kidneys, nerves, heart, and blood vessels. 1 As reported by the American Diabetes Association, approximately 18.2 million people in the United States, or 6.2% of the population, have diabetes. While an estimated 11.1 million people have been diagnosed, unfortunately, 5.9 million people (or one-third) are unaware they have diabetes. 2 The prevalence of diabetes in the United States is increasing. 3 This epidemic is impacting healthcare costs. Diabetes is one of the most costly and burdensome chronic diseases of our time and is in epidemic proportions in the United States and throughout the world. 4 Not surprisingly, this directly correlates with the increased incidence of obesity in the United States. Also alarming is the disproportionate increase of type 2 diabetes in children. Research shows that there is a correlation in the decreased activity levels and increased weight of our youth. 5 In 1996, more than 3.8 million hospitalizations were associated with diabetes, accounting for 25 million hospital days with an average length of stay of 6.5 days. 6 The absolute number of diabetes-related hospitalizations increased by more than 70% from 1980 to 1996, although the average length of stay declined from 11 to 6.5 days. The most common reason for hospitalization among patients with diabetes is disease involving the circulatory system, which in 1996 accounted for 36% of hospitalizations in this group, followed by diseases of the respiratory system and infections. 7 The increasing numbers of hospital patients with diabetes demands a thorough understanding of the normal and altered physiology of diabetes.
NORMAL METABOLISM
Glucose is the body's chief metabolic fuel. It is the only fuel the brain can utilize. Normal fasting blood glucose is 60 to 110 mg/dL; levels rise after meals, but the body quickly restores homeostasis. Since the brain cannot store glucose, a steady supply of glucose in the blood is needed. The body stores glucose as glycogen in the liver and muscles and draws on these stores as needed. The body's glycogen supply provides about 1 day's supply of glucose (for the adult). During prolonged fasting or an illness or injury, fats and proteins can be converted to provide fuel for the body. 8 Maintaining normoglycemia is a constant balancing act for the body.
For many years following the discovery of insulin in the 1920s, it was believed that glucose homeostasis was maintained solely through the action of insulin. The discovery of glucagon in the 1950s broadened the picture of glucose metabolism. In recent years, many more hormones have been discovered to have roles in metabolic control. Amylin, gastric inhibitory peptide (GIP), glucagon-like peptide 1 (GLP-1), ghrelin, peptideYY 3-36 (PYY), cholecystokinin (CCK), and other hormones also impact glucose homeostasis.
The islets of Langerhans in the pancreas contain α-cells and β-cells. The islets respond to changing blood glucose levels with hormonal secretions. The β-cells secrete insulin and amylin in response to rising blood glucose levels and both are co-secreted proportionally. Insulin lowers blood glucose by facilitating glucose uptake by the cells for use as fuel, as well as to store glucose in the liver and muscle as glycogen. Insulin inhibits glucagon secretion during hyperglycemia and also facilitates lipid storage and protein synthesis. 8 Amylin also inhibits glucagon secretion when blood glucose is elevated and regulates gastric emptying to permit gradual absorption of nutrients when blood glucose is high. 9 In contrast, the α-cells secrete the hormone glucagon in response to lower blood glucose levels. Glucagon raises blood glucose through gluconeogenesis and inhibition of glycogen synthesis. Glycogen stores are converted to glucose to maintain blood glucose levels between meals when the blood glucose drops.
Incretins are gut hormones that are secreted postprandially. Incretins such as GIP, GLP-1, and CCK stimulate insulin secretion after meals in response to rising blood glucose. 10, 11 They also have a role in regulating glucagon secretion and gastric emptying. Other gut hormones such as ghrelin and PYY inhibit insulin secretion and may help regulate appetite. 12 New hormones are continually being discovered and researchers are investigating their actions. While insulin is a major factor in glucose regulation, maintaining glucose homeostasis is a multihormonal task.
PATHOPHYSIOLOGY
Diabetes mellitus is a group of diseases characterized by hyperglycemia and disordered carbohydrate, protein, and fat metabolism, but with different pathogeneses. The hyperglycemia results from defects in β-cell function and/or insulin action. 13 The β-cell dysfunction may be caused by autoimmune destruction, acquired dysfunction, or inherited dysfunction. Symptoms of acute hyperglycemia include polydipsia, polyuria, headache, poor wound healing, and impaired resistance to infections. Chronic complications include, but are not limited to, retinopathy, neuropathy, and nephropathy. Acute complications of diabetes may be life-threatening and include ketoacidosis, hyperglycemic hyperosmolar state (HHS; described in earlier literature as HHNS [hyperglycemic hyperosmolar nonketotic syndrome]), and severe hypoglycemia.
TYPE 1
Type 1 diabetes is caused by autoimmune destruction of the β-cells in the pancreas. It is characterized by sudden onset of hyperglycemia and often ketoacidosis. Most people develop type 1 diabetes before the age of 30, but it can occur at any age. The individual with type 1 diabetes must have insulin to survive. Today a variety of insulins and methods of insulin delivery are available to provide flexibility and more physiologic insulin therapy.
The onset of type 1 diabetes is typically sudden, but the pathologic changes in the pancreas occur over as many as 9 years before clinical symptoms appear. Evidence suggests a genetic predisposition to type 1 diabetes. The presence of HLA-DQ coded genes is strongly linked with its occurrence. Specific genes seem to be necessary but not sufficient for the development of the disease, as there is only a 50% concordance rate of type 1 diabetes in identical twins. A trigger is necessary for the genetic expression; many experts point to environmental triggers. 13 Certain viral infections such as congenital rubella syndrome and Coxsackie B4 are associated with development of type 1 diabetes. Early exposure to cow's milk has also been associated. Recent studies suggest that the timing of feeding babies cereal may affect the risk of islet autoimmunity.
14 Whatever the trigger, the autoimmunity process is activated against the pancreatic β-cells and insulin. Islet cell antibodies attack the pancreas and insulin autoantibodies interfere with insulin action. The gradual destruction of the β-cells continues; the pancreas can maintain normoglycemia with as little as 10% remaining insulin-secreting capacity. An acute illness or stress may increase the insulin demand beyond the capabilities of the damaged pancreas, precipitating hyperglycemia and diabetes. As the illness or stress resolves, the individual may once again be able to meet normal insulin demands and maintain normoglycemia. This period of several weeks to months, during which little or no exogenous insulin is needed, is called the honeymoon phase. β-Cell damage continues and the individual again requires insulin and permanently has type 1 diabetes.
TYPE 2
Type 2 diabetes is the most prevalent form of the disease. The gradual onset of type 2 diabetes often results in diabetes, which is often undiagnosed for many years. The risk of type 2 diabetes increases with age. Many people who develop type 2 diabetes are over 40 years of age, are likely to be overweight, are not physically active, and have a family history of diabetes. Other conditions such as hypertension, hyperlipidemia, polycystic ovary syndrome (PCOS), and past history of gestational diabetes increase the risk of developing diabetes. Racial and ethnic minorities also have an increased risk of type 2 diabetes. 15 It is strongly inherited; an individual has a 7% to 14% chance of developing type 2 diabetes if one parent has it. The concordance rate in identical twins is over 90% if one twin has type 2. While it usually appears after age 40, the rate of type 2 diabetes in the young (often called maturity onset-type diabetes in youth) is rapidly increasing. Childhood obesity and inactivity contribute to this increase.
Insulin resistance, in which the cells become less sensitive to insulin, combines with β-cell dysfunction, resulting in hyperglycemia. Individuals with type 2 diabetes may have as little as half the β-cell mass as someone without diabetes. β-Cells that are continually exposed to high levels of glucose become less sensitive to glucose levels and less responsive to hyperglycemia, a condition known as glucose toxicity. 13 Abnormal glucagon secretion, especially postprandially, further impairs glycemic control.
Early in the course of the disease, some individuals may manage type 2 diabetes with diet and exercise, but most will require medication. A variety of medications are available to treat type 2 diabetes and many individuals use 2 or more drugs. Oral medications are formatted to stimulate the β-cells to secrete more insulin, to slow absorption of carbohydrates, to reduce gluconeogenesis from the liver, and to make the cells more sensitive to insulin. As β-cell function declines, oral medications are no longer adequate to control diabetes. Therefore, insulin may be given in addition to or instead of oral medications.
Individuals with type 2 diabetes who take oral medications often need insulin during acute illness and injuries. They may not be able to take oral medications during acute illness or surgery. The body's response to stress raises levels of counterregulatory hormones, including epinephrine, glucagon, and cortisol. The increased blood glucose may require more insulin than the body is able to secrete.
Although hyperglycemia is seen as a common sign of all types of diabetes, proper diagnosis is essential to appropriate treatment.
DIAGNOSTIC CRITERIA FOR DIABETES MELLITUS
There are 3 ways to diagnose diabetes. Each way must be confirmed on a subsequent day, by any of the following methods.
Criteria for the diagnosis of diabetes mellitus 1. Symptoms of diabetes plus casual plasma glucose concentration ≥200 mg/dL (11.1 mmol/L). Casual is defined as any time of day without regard to time since the last meal. The classic symptoms of diabetes include polyuria, polydipsia, and unexplained weight loss. or 2. Fasting plasma glucose (FPG) ≥126 mg/ dL (7.0 mmol/L). Fasting is defined as no caloric intake for at least 8 h. or 3. 2-h postprandial glucose (PG) ≥200 mg/ dL (11.1 mmol/L). During an oral glucose tolerance test (OGTT) the test should be performed as described by the World Health Organization, using a glucose load containing the equivalent of 75 g anhydrous glucose dissolved in water.
Note. In the absence of unequivocal hyperglycemia with acute metabolic decompensaion, these criteria should be confirmed by repeat testing on a different day. The third measure (OGTT) is not recommended for routine clinical use. 4 Testing should be done at anytime the symptoms presented by an individual are consistent with those of diabetes. In type 1 diabetes, the symptoms are usually acute. The blood glucose levels are unequivocally elevated. Undiagnosed type 2 diabetes is common in the United States. Of concern, there is epidemiological evidence that retinopathy begins to develop at least 7 years before the clinical diagnosis of type 2 diabetes is made. 6 Because hyperglycemia in type 2 diabetes causes microvascuslar disease and may cause or contribute to macrovascular disease, undiagnosed diabetes is a serious condition. Patients with undiagnosed type 2 diabetes are at significantly increased risk for coronary heart disease, stroke, and peripheral vascular disease. In addition, they have a greater likelihood of having dyslipidemia, hypertension, and obesity. 7 Early detection and subsequent treatment may well reduce the burden of type 2 diabetes and its complications. However, to increase the cost-effectiveness of testing undiagnosed but otherwise healthy individuals, testing should be considered in high-risk populations. The following are the suggested criteria. The testing for diabetes may uncover a fasting blood glucose that is higher than normal (>100 mg/dL), but not high enough for the diagnosis of type 2 diabetes. This condition is known as prediabetes and is a risk factor for the development of the actual disease. It is estimated that at least 16 million Americans have prediabetes in addition to the 17 million with diabetes. 17 
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Special considerations in nursing care of patients with diabetes
The percentage of people with diabetes is increasing at an alarming rate. This necessarily increases the number of critical care patients with diabetes. Whether diabetes is the primary diagnosis or a complicating secondary diagnosis, patients with diabetes require careful attention to their metabolic status.
Diabetes requires special considerations in caring for critical care patients. Patients with diabetes have a greater risk of macrovascular disease, nephropathy, neuropathy, and retinopathy. 18 Cardiovascular disease accounts for over 50% of all deaths in patients with diabetes. 19 Patients should be carefully assessed for alterations in body systems. Impaired circulation increases the risk of skin breakdown with bed rest and the risk of injury from application of heat or cold. Neuropathy increases the risk of injury due to impaired sensation. Renal status is an important consideration in fluid management and must be carefully assessed before diagnostic tests requiring dye.
Medications a patient has been taking must be carefully assessed. In addition to insulin and/or oral diabetes medications, many patients with diabetes may be taking medications for hypertension and hyperlipidemia. Patients without these conditions may still be taking aspirin and other medications such as statins, angiotensin-converting enzyme (ACE) inhibitors, and angiotensin receptor blockers for prevention of heart disease and renal disease.
Maintaining glucose homeostasis is important to avoid complications caused by hyperglycemia or hypoglycemia. Even if hyperglycemia is not the primary diagnosis, it may quickly become a life-threatening complication. Hyperglycemia impairs wound healing and increases susceptibility to infection by impairing white blood cell motility. Hyperglycemia increases the incidence of complications following myocardial infarction and during the perioperative and postoperative periods. 20 Hypoglycemia may be difficult to assess in patients who are acutely ill, sedated, those with altered mental status, or who have developed unawareness. Bedside glucose monitoring is a key tool in recognizing alterations in glucose homeostasis.
DIABETIC KETOACIDOSIS
Individuals with type 1 diabetes are at risk for diabetic ketoacidosis (DKA). DKA may be the presenting symptom in the initial diagnosis of type 1 diabetes. Illness and infection are the most common causes of DKA. They raise glucocorticoid levels as well as epinephrine and norepinephrine levels, promoting gluconeogenesis and glycogenolysis, which increase blood glucose levels. Individuals who are ill and unable to eat may omit their insulin, further raising blood glucose levels. 21 Emotional stress may also be a factor in developing DKA. Some individuals may even deliberately induce hyperglycemia in order to lose weight.
DKA is caused by extreme insulin deficiency. Diagnostic criteria for DKA include hyperglycemia (serum glucose >250 mg/dL), pH ≤7.3, serum bicarbonate ≤15 mEq/L, and ketones in urine or blood. 22 Insulin deficiency impairs metabolism of carbohydrates as well as proteins and fats. Glucose cannot be utilized for energy or stored, and thus blood glucose rises. Impaired protein synthesis promotes gluconeogenesis and hyperglycemia. Lipolysis of triglycerides results in glycerol and free fatty acids, increasing gluconeogenesis and ketogenesis. The body attempts to reduce hyperglycemia through osmotic diuresis, resulting in dehydration and electrolyte depletion. As ketonemia exceeds the body's buffering capacity, acidosis ensues.
Symptoms of DKA may initially seem like a mild illness and rapidly worsen as the metabolic state declines. Assessment of the patient with DKA typically reveals a recent history of polyuria, polydipsia, dehydration, and weakness. There may also be nausea, vomiting, and abdominal pain. Acetone breath (a fruity odor) may be present as ketone bodies are converted to acetone and excreted through the lungs. Rapid, deep breathing, Kussmaul respiration, is the body's attempt to correct metabolic acidosis. Physical assessment may reveal poor skin turgor, tachycardia, hypotension, and altered mental status. 22 Treatment of DKA focuses on correction of hyperglycemia, dehydration, and electrolyte imbalance. It is important to identify comorbidities and precipitating factors. Patient education is essential to preventing recurrent DKA. IV fluid therapy is begun with 0.9% NaCl at 15 to 20 ml/kg in the first hour and adjusted as needed. Unless DKA is mild, regular insulin is given by IV infusion. An initial bolus of 0.15 units/kg is followed with an infusion rate of 0.1 units/(kg/h). The hourly insulin infusion rate may be doubled until blood glucose falls by 50 to 70 mg/dL/h. When the glucose reaches 250 mg/dL, fluids and insulin are adjusted to gradually restore metabolic control. Severe dehydration may cause elevated serum potassium even though total-body potassium may be depleted. 
HYPERGLYCEMIC HYPEROSMOLAR STATE
Hyperglycemic hyperosmolar state (HHS) most often occurs in older patients with type 2 diabetes, but may also be seen in older type 1 diabetes. The insulin deficiency is less profound than in DKA and so ketosis does not occur. Symptoms develop gradually over days or weeks and may not be noticed until they are extreme. HHS is most often caused by concomitant illness or other stress.
The patient with HHS exhibits severe hyperglycemia, extreme dehydration, and altered neurologic state. Diagnostic criteria for HHS include serum glucose >600 mg/dL, serum osmolality >320 mOsm/kg, and normal pH and serum bicarbonate. The pathophysiology is similar to DKA except lipolysis does not occur. Hyperglycemia may go unnoticed until prolonged osmotic diuresis causes extreme dehydration and altered mental status. The often-delayed diagnosis increases mortality owing to HHS. Assessment of the patient with HHS typically reveals a history of polyuria, polydipsia, dehydration, and weakness for several days to 2 weeks. In contrast to DKA, Kussmaul respirations are seldom observed, nor is acetone breath since there is no ketosis. Gastrointestinal symptoms are milder than in DKA. Physical assessment may reveal poor skin turgor, tachycardia, and hypotension. Lethargy and mental confusion are common. 22 Treatment of HHS focuses on rehydration and reducing hyperglycemia. As with DKA, it is important to identify comorbidities and precipitating factors. Education of the patient, family, and caregivers is essential to preventing recurrent HHS. IV fluid therapy is begun with 0.9% NaCl at 15 to 20 ml/kg in the first hour and adjusted as needed. Regular insulin is given by IV infusion. An initial bolus of 0.15 units/kg is followed with an infusion of 0.1 units/(kg/h). The hourly insulin infusion rate may be doubled until blood glucose falls by 50 to 70 mg/dL/h. When the glucose reaches 300 mg/dL, fluids and insulin are adjusted to gradually restore metabolic control. Severe dehydration may cause elevated serum potassium even though total-body potassium may be depleted. If serum K + is ≥5.0mEq/L, it is monitored closely. If serum K + is between 3.3 and 5.0 mEq/L, 20 to 40 mEq/L of potassium is added to IV fluids (2/3 KCl and 1/3 KPO 4 ) to maintain serum K + at 4 to 5 mEq/L. 22 The most common complications of DKA and HHS are hypoglycemia and hypokalemia when glucose and potassium levels are not carefully monitored as insulin is given. Another problem is discontinuing IV insulin without beginning subcutaneous insulin. As with DKA, fluid replacement depends on the patients cardiovascular status. Care must be taken to avoid fluid overload in elderly patients. Careful monitoring of the patient's rapidly changing fluid and electrolyte status is crucial to safe resolution of DKA and HHS.
SUMMARY
Diabetes mellitus is a common disease seen in many hospitalized patients. The basics of the disease process and special considerations for hospitalized patients are important to understand. Better control of blood glucose and patient education will lead to decrease in complications both acute and chronic. It is important that all members of the healthcare team understand the importance of control and management of the disease.
